Drugs by condition
Drugs approved for ptsd
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
3
Still marketed, NDA or BLA
Drug classes
1
Novel drugs
2
New molecular entities and new biologics
In development
1
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for ptsd.
All approved drugs for ptsd, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 20 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Drugs in development for ptsd
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- RE03Phase 21 trial
Reconnect Labs · Posttraumatic Stress Disorder (PTSD), Sleep Disturbances and Insomnia
More on ptsd: recruiting trials · published research
Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · ADHD · Anxiety disorders · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · Postpartum depression
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.